Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Y-mAbs Therapeutics, Inc. | Director | Common stock | 4.56M | $9.12M | $2.00 | Dec 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics, Inc. | Dec 11, 2023 | 1 | $44.2K | 4 | Dec 12, 2023 | Director |
YMAB | Y-mAbs Therapeutics, Inc. | Dec 7, 2023 | 3 | $890K | 4 | Dec 11, 2023 | Director |
YMAB | Y-mAbs Therapeutics, Inc. | Nov 29, 2023 | 1 | $309K | 4 | Dec 1, 2023 | Director |
YMAB | Y-mAbs Therapeutics, Inc. | Nov 27, 2023 | 2 | $521K | 4 | Nov 29, 2023 | Director |
YMAB | Y-mAbs Therapeutics, Inc. | May 15, 2023 | 1 | $981K | 4 | May 17, 2023 | Director, Other* |
YMAB | Y-mAbs Therapeutics, Inc. | Jun 10, 2021 | 1 | -$406K | 4 | Jun 11, 2021 | Director, Other* |
YMAB | Y-mAbs Therapeutics, Inc. | Jun 8, 2021 | 2 | -$5.4M | 4 | Jun 10, 2021 | Director, Other* |
YMAB | Y-mAbs Therapeutics, Inc. | Jun 7, 2021 | 1 | -$2.47M | 4 | Jun 9, 2021 | 10%+ Owner |
YMAB | Y-mAbs Therapeutics, Inc. | Jun 3, 2021 | 2 | -$1.15M | 4 | Jun 7, 2021 | 10%+ Owner |
YMAB | Y-mAbs Therapeutics, Inc. | May 28, 2021 | 2 | -$1.15M | 4 | Jun 2, 2021 | 10%+ Owner |